West expands contracting manufacturing capabilities in Ireland

Provider of innovative solutions for injectable drug administration West Pharmaceutical Services has completed a 60,000 square foot expansion at its contract manufacturing facility near Mulhuddart, County Dublin.

The expansion represents West’s most recent investment in Ireland where the company is also building a new pharmaceutical component manufacturing facility and is due to customer demand for medical device manufacturing.

West will also align its contract manufacturing business, formerly known as The Tech Group, with the West brand and do business as “West”.

The additional capacity at the Dublin facility will aid West in providing a better service for high-quality moulding and assembly solutions for the production of medical devices. The expansion will also provide an estimated 100 jobs within the business over the next five years.

Karen Flynn, senior vice president and chief commercial officer said: “As the healthcare market becomes increasingly complex, West is advancing our core competencies in the development, manufacturing and final packaging of complex drug delivery systems and diagnostic devices for our customers. We are excited about the growth and expansion we are experiencing in both our contract manufacturing business in Dublin as well as our proprietary products business in Waterford, both of which will support increasing demand from our global customer base.”  

West is also furthering operations in Ireland by growing its proprietary product business in Waterford. The company has announced the construction of a centre of excellence which is expected to begin full commercial operations in 2018.

Mary Mitchell O’Connor, Ireland’s minister for Jobs, Enterprise & Innovation said: “With this most recent expansion in Dublin and the company’s previously announced investment in Waterford, West is affirming its presence as an important employer in Ireland. I am delighted with this new investment, which strongly aligns with the Government's ongoing strategy to attract investment in high-quality, high-value, medical device manufacturing to Ireland. We look forward to strengthening our relationship with West.”